NO20033857L - Benzofenoner som inhibitorer av revers transkriptase - Google Patents
Benzofenoner som inhibitorer av revers transkriptaseInfo
- Publication number
- NO20033857L NO20033857L NO20033857A NO20033857A NO20033857L NO 20033857 L NO20033857 L NO 20033857L NO 20033857 A NO20033857 A NO 20033857A NO 20033857 A NO20033857 A NO 20033857A NO 20033857 L NO20033857 L NO 20033857L
- Authority
- NO
- Norway
- Prior art keywords
- benzophenones
- inhibitors
- reverse transcriptase
- transcriptase
- reverse
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
- C07C311/46—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/51—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/52—Y being a hetero atom
- C07C311/53—X and Y not being nitrogen atoms, e.g. N-sulfonylcarbamic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27295301P | 2001-03-02 | 2001-03-02 | |
| PCT/US2002/006037 WO2002070470A2 (en) | 2001-03-02 | 2002-02-28 | Benzophenones as inhibitors of reverse transcriptase |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20033857D0 NO20033857D0 (no) | 2003-09-01 |
| NO20033857L true NO20033857L (no) | 2003-10-27 |
Family
ID=23041935
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20033857A NO20033857L (no) | 2001-03-02 | 2003-09-01 | Benzofenoner som inhibitorer av revers transkriptase |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US6995283B2 (no) |
| EP (1) | EP1363877A2 (no) |
| JP (1) | JP2004525914A (no) |
| KR (1) | KR100638954B1 (no) |
| CN (1) | CN1494528A (no) |
| AR (2) | AR035436A1 (no) |
| AU (1) | AU2002254056C1 (no) |
| BR (1) | BR0207752A (no) |
| CA (1) | CA2439820A1 (no) |
| CZ (1) | CZ20032366A3 (no) |
| HU (1) | HUP0303326A2 (no) |
| IL (1) | IL157348A0 (no) |
| MX (1) | MXPA03007883A (no) |
| NO (1) | NO20033857L (no) |
| NZ (1) | NZ527864A (no) |
| PL (1) | PL364658A1 (no) |
| WO (1) | WO2002070470A2 (no) |
| ZA (1) | ZA200306549B (no) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3429B1 (ar) | 2001-08-13 | 2019-10-20 | Janssen Pharmaceutica Nv | مشتقات برميدينات مثبطة فيروس الايدز |
| US7638522B2 (en) | 2001-08-13 | 2009-12-29 | Janssen Pharmaceutica N.V. | Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino] benzonitrile |
| US8101629B2 (en) | 2001-08-13 | 2012-01-24 | Janssen Pharmaceutica N.V. | Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile |
| AR039540A1 (es) | 2002-05-13 | 2005-02-23 | Tibotec Pharm Ltd | Compuestos microbicidas con contenido de pirimidina o triazina |
| US7399856B2 (en) | 2002-08-09 | 2008-07-15 | Janssen Pharmaceutica N.V. | Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-2pyrimidinyl]amino]benzonitrile |
| CA2496565C (en) | 2002-08-23 | 2013-04-02 | Ribapharm Inc. | Non-nucleoside reverse transcriptase inhibitors |
| US7642277B2 (en) | 2002-12-04 | 2010-01-05 | Boehringer Ingelheim International Gmbh | Non-nucleoside reverse transcriptase inhibitors |
| JP5602333B2 (ja) * | 2003-02-07 | 2014-10-08 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Ｈｉｖ感染の予防のためのピリミジン誘導体 |
| WO2004087881A2 (en) | 2003-03-27 | 2004-10-14 | Smithkline Beecham Corporation | Process for preparing reverse transcriptase inhibitors |
| WO2005026114A1 (en) * | 2003-09-17 | 2005-03-24 | Pfizer Inc. | Hiv protease inhibitors, compositions containing the same and their pharmaceutical uses |
| WO2005100322A1 (en) * | 2004-04-14 | 2005-10-27 | Pfizer Limited | Sulphur-linked imidazole compounds for the treament of hiv |
| US20060025480A1 (en) * | 2004-08-02 | 2006-02-02 | Boehringer Ingelheim International Gmbh | Benzoic acid derivatives as non nucleoside reverse transcriptase inhibitors |
| EP2433633A1 (en) | 2004-08-25 | 2012-03-28 | Ardea Biosciences, Inc. | Triazolyl alpha -mercaptoacetanildes as inhibitors of HIV reverse transcriptase |
| WO2007050087A1 (en) | 2004-08-25 | 2007-05-03 | Ardea Biosciences, Inc. | N[S(4-aryl-triazol-3-yl)α -mercaptoacetyl]-p-amino benozoic acids AS HIV REVERSE TRANSCRIPTASE INHIBITORS |
| EP1797062B8 (en) * | 2004-09-30 | 2011-05-25 | Boehringer Ingelheim International GmbH | Alkynyl based dervatives of benzophenone as non-nucleoside reverse transcriptase inhibitors |
| CA2592092A1 (en) * | 2004-12-22 | 2006-06-29 | Pfizer Limited | Nonnucleoside inhibitors of hiv-1 reverse transcriptase |
| SG161256A1 (en) * | 2005-04-08 | 2010-05-27 | Abbott Lab | Oral pharmaceutical formulations comprising fenofibric acid and/or its salts |
| AR057455A1 (es) * | 2005-07-22 | 2007-12-05 | Merck & Co Inc | Inhibidores de la transcriptasa reversa de vih y composicion farmaceutica |
| PE20071226A1 (es) * | 2006-04-17 | 2008-01-24 | Smithkline Beecham Corp | Compuesto derivado de acetamida como inhibidor de transcriptasa inversa no nucleosido |
| WO2007121415A2 (en) * | 2006-04-17 | 2007-10-25 | Smithkline Beecham Corporation | Chemical compounds |
| TW200808694A (en) * | 2006-04-17 | 2008-02-16 | Smithkline Beecham Corp | Chemical compounds |
| MX2009000871A (es) * | 2006-07-24 | 2009-05-08 | Gilead Sciences Inc | Novedosos inhibidores de transcriptasa inversa de vih. |
| CN101407476B (zh) * | 2007-10-12 | 2012-07-18 | 中国人民解放军军事医学科学院毒物药物研究所 | 作为非核苷类hiv逆转录酶抑制剂的间二芳烃-多取代苯胺类化合物、其制备方法及用途 |
| DK2217577T3 (da) | 2007-11-27 | 2014-10-20 | Ardea Biosciences Inc | Hidtil ukendte forbindelser og præparater og fremgangsmåder til anvendelse deraf |
| CN101450911B (zh) * | 2007-11-30 | 2012-02-29 | 山东轩竹医药科技有限公司 | 被金刚烷取代的苯甲酸衍生物 |
| CN102212022A (zh) * | 2011-04-20 | 2011-10-12 | 复旦大学 | 二苯甲醇衍生物及其制备方法和用途 |
| CN102219717A (zh) * | 2011-04-20 | 2011-10-19 | 复旦大学 | N-苯基芳基甲酰胺衍生物及其制备方法和用途 |
| CN102206177A (zh) * | 2011-04-20 | 2011-10-05 | 复旦大学 | 1-萘基苯甲酮衍生物及其制备方法和用途 |
| CN110015963A (zh) * | 2019-04-12 | 2019-07-16 | 上海优合生物科技有限公司 | 一种2-氯-6-甲基苯胺的制备方法 |
| US11116737B1 (en) | 2020-04-10 | 2021-09-14 | University Of Georgia Research Foundation, Inc. | Methods of using probenecid for treatment of coronavirus infections |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03198050A (ja) * | 1989-12-27 | 1991-08-29 | Fuji Photo Film Co Ltd | ハロゲン化銀カラー写真感光材料 |
-
2002
- 2002-02-28 CN CNA028058828A patent/CN1494528A/zh active Pending
- 2002-02-28 JP JP2002569791A patent/JP2004525914A/ja not_active Ceased
- 2002-02-28 AU AU2002254056A patent/AU2002254056C1/en not_active Ceased
- 2002-02-28 WO PCT/US2002/006037 patent/WO2002070470A2/en active IP Right Grant
- 2002-02-28 CZ CZ20032366A patent/CZ20032366A3/cs unknown
- 2002-02-28 PL PL02364658A patent/PL364658A1/xx not_active Application Discontinuation
- 2002-02-28 EP EP02723265A patent/EP1363877A2/en not_active Withdrawn
- 2002-02-28 CA CA002439820A patent/CA2439820A1/en not_active Abandoned
- 2002-02-28 IL IL15734802A patent/IL157348A0/xx unknown
- 2002-02-28 MX MXPA03007883A patent/MXPA03007883A/es unknown
- 2002-02-28 HU HU0303326A patent/HUP0303326A2/hu unknown
- 2002-02-28 US US10/469,104 patent/US6995283B2/en not_active Expired - Fee Related
- 2002-02-28 BR BR0207752-3A patent/BR0207752A/pt not_active IP Right Cessation
- 2002-02-28 KR KR1020037011471A patent/KR100638954B1/ko not_active IP Right Cessation
- 2002-02-28 NZ NZ527864A patent/NZ527864A/en unknown
- 2002-03-01 AR ARP020100764A patent/AR035436A1/es not_active Application Discontinuation
-
2003
- 2003-08-21 ZA ZA200306549A patent/ZA200306549B/xx unknown
- 2003-09-01 NO NO20033857A patent/NO20033857L/no not_active Application Discontinuation
-
2004
- 2004-02-23 AR ARP040100563A patent/AR043367A2/es not_active Application Discontinuation
-
2005
- 2005-09-09 US US11/223,634 patent/US20060009651A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20040122064A1 (en) | 2004-06-24 |
| US6995283B2 (en) | 2006-02-07 |
| PL364658A1 (en) | 2004-12-13 |
| AU2002254056B2 (en) | 2005-09-29 |
| US20060009651A1 (en) | 2006-01-12 |
| WO2002070470A2 (en) | 2002-09-12 |
| WO2002070470A3 (en) | 2003-03-06 |
| AR035436A1 (es) | 2004-05-26 |
| IL157348A0 (en) | 2004-02-19 |
| JP2004525914A (ja) | 2004-08-26 |
| BR0207752A (pt) | 2004-03-23 |
| ZA200306549B (en) | 2004-11-22 |
| KR100638954B1 (ko) | 2006-10-25 |
| NZ527864A (en) | 2004-05-28 |
| CN1494528A (zh) | 2004-05-05 |
| HUP0303326A2 (hu) | 2004-01-28 |
| KR20030086283A (ko) | 2003-11-07 |
| EP1363877A2 (en) | 2003-11-26 |
| MXPA03007883A (es) | 2003-12-04 |
| CZ20032366A3 (en) | 2004-04-14 |
| NO20033857D0 (no) | 2003-09-01 |
| CA2439820A1 (en) | 2002-09-12 |
| AR043367A2 (es) | 2005-07-27 |
| AU2002254056C1 (en) | 2006-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20033857L (no) | Benzofenoner som inhibitorer av revers transkriptase | |
| NO20021042D0 (no) | Benzofenoner som inhibitorer av revers transkriptase | |
| NO20033593D0 (no) | Kinazoliner som MMP-13 inhibitorer | |
| NO20043004L (no) | 4-oksokinolin forbindelse og anvendelse derav som HIV-integraseinhibitor | |
| NO20043726L (no) | Heteroarylforbindelser anvendelige som inhibitorer av GSK-3 | |
| NO20041180L (no) | Pyrrolopyrimidiner som midler for inbibering av cysteinprotaser | |
| NO20030867L (no) | Hydroksamderivater anvendelig som deacetylaseinhibitorer | |
| NO20043158L (no) | Substituerte kinazolinderivater som inhibitorer av aurorakinaser | |
| NO20033618L (no) | Ftalayinon-piperidino-derivater som PDE-4-inhibitorer | |
| DK1544199T3 (da) | Nitrogenholdig kondenseret ringforbindelse og anvendelse deraf som HIV-integraseinhibitor | |
| NO20050563L (no) | N-aryl-piperidinsubstituerte bifenylkarboksamider som inhibitorer av apolipoprotein B-sekresjon | |
| NO20041887L (no) | Benzomidazoler anvendelige som proteinkinase-inhibitorer | |
| DK1560584T3 (da) | Fab I inhibitorer | |
| NO20026262L (no) | Cyklopentyl-substituerte glutaramidderivater som inhibitorer av nöytral endopeptidase | |
| ATE370124T1 (de) | Inhibitoren dernicht-nukleosid-inhibitoren der reversen transkriptase | |
| NO20042719L (no) | Substituerte 2-amino-cykloalkankarboksamider og deres anvendelse som protease-inhibitorer | |
| DK1458447T3 (da) | Kombination af cytokrom-p450-beroende proteasinhibitorer | |
| DK1294720T3 (da) | Non-nukleosid revers transkriptase-inhibitorer | |
| NO20042938L (no) | Nitrogenholdige forbindelser som korrosjonsinhibitorer | |
| NO20044104L (no) | Ikke-nukleoside reverstranskriptase-inhibitorer | |
| NO20043424L (no) | Tricykliske 2-pyrimidon forbindelser nyttige som HIV revers transkriptase inhibitorer | |
| NO20033700D0 (no) | Isoksazolinderivater som anti-depressive midler | |
| DK1373261T3 (da) | Cyklopropaheterocykler som non-nukleotid revers transkriptase-hæmmer | |
| NO20041909L (no) | Nye forbindelser og sammensetninger som katepsin S-inhibitorer | |
| NO20030248L (no) | Tricykliske pyridonforbindelser anvendelige som HIV revers- transkriptase-inhibitorer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |